SARS-CoV-2 Spike receptor binding domain, RBD (336-347)

SARS-CoV-2 Spike receptor binding domain, RBD (336-347)

For laboratory research purposes only. Not for human or veterinary use.

Purity: ≥ 95%

CAT.NO: P400522

Categories: , ,

Inquiry
Description

Product Name: SARS-CoV-2 Spike receptor binding domain, RBD (336-347)

Sequence One Letter Code: CPFGEVFNATRF

Sequence Three Letter Code: H-Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe-OH

Molecular Weight: 1387.6

Purity: ≥ 95%

Storage Conditions: - 20 °C

Source / Species: SARS-CoV-2

Conjugation: Unconjugated

Code Nacres: NA.26

Application: SARS-CoV-2 Spike RBD (336–347) is a synthetic peptide corresponding to residues 336–347 of the SARS-CoV-2 spike receptor-binding domain, based on RefSeq YP_009724390.1. The RBD is essential for viral attachment to the host ACE2 receptor and is a major target for neutralizing antibodies. This focused peptide sequence is useful for studying spike protein structure, epitope mapping, antibody screening, immune recognition, and vaccine-related research. SARS-CoV-2 Spike RBD (336–347) provides a targeted tool for investigating receptor-binding domain function and spike-mediated host interactions. 

Get a Quote

No products in the cart.